Gastric Type I Neuroendocrine Tumors Endoscopic Treatment Options Abstract #1519

Introduction: From 1998 till 2014 in our institution we have identified 72 patients with type I gastric neuroendocrine tumors (NET), 42 of them, without regional or distant metastases, undergone different types of endoscopic treatment.
Aim(s): In patients (21) with type I flat G1 lesions 0,5 cm and smaller, located within mucosa, we have used argon-plasma coagulation (APC). Mean tumor amount, destructed with APC was 14, mean size – 0,4 cm. We have not observed any tumor recurrence at treatment sites, but in 28,5% patients new G1 NETs were developed within 1 year after treatment in different mucosal areas.
Materials and methods: Mean amount of de novo tumors was 4,4, mean size – 0,2 cm. In all cases second phase APC was implemented. Patients (18) with gastric type 1 G1 NETs sized 0,5 – 1 cm undergone endoscopic mucosal resection (EMR). In 72,2% of them we have diagnosed simultaneously small (less than 0,5 cm) and bigger (0,5 – 1 cm) tumors, so EMR was performed in parallel with APC.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: Dr. Sergey Pirogov
Keywords: gastric, NET, endoscopic, EMR, ESD, APC

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1512 Type I Gastric Neuroendocrine Tumors Diagnostics: 16 Years of Experience
Introduction: In our institution from 1998 to 2014 we have identified 72 patients with type I gastric neuroendocrine tumors (NET).
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dr. Sergey Pirogov
#1513 Multimodal Endoscopic Diagnostics of Gastric Type I Neuroendocrine Tumors
Introduction: From 1998 till 2014 in our institution we have diagnosed 72 type I gastric neuroendocrine tumors (NET) with upper gastrointestinal endoscopy.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dr. Sergey Pirogov
#1516 Multimodal Endoscopic Diagnostics of Gastric Neuroendocrine Tumors
Introduction: From 1998 till 2014 in our institution we have diagnosed 72 type I gastric neuroendocrine tumors (NET) with upper gastrointestinal endoscopy.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dr. Sergey Pirogov
#2709 Endoscopic Management and Outcomes of Gastro-Duodenal Neuroendocrine Tumours
Introduction: Gastric and duodenal neuroendocrine tumours are increasing in incidence. ENETS guidelines suggest endoscopic resection of type 1 gastric NENs over 10mm and consider endoscopic resection for duodenal NENs. However, the endoscopic techniques are not clearly mandated. There, is evidence to suggest endoscopic mucosal dissection has higher incidence of R0 resections compared with polypectomy or EMR alone.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Endocrine malignancies (MTC, pheochromocytoma) - diagnosis and therapy
Presenting Author: Alexandra Victor
#2711 Gastric Neuroendocrine Neoplasms: Clinical Management and Outcomes in a Cohort of 54 Patients
Introduction: Gastric NENs are increasingly being diagnosed at endoscopy. The majority of these are type 1 gastric NEN. However, around 10-20% can be type 3 or type 4 Gastric NENs.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Surgical treatment and Ablative Therapies
Presenting Author: Alexandra Victor
Authors: Victor A, Ramage J, Cope J, Maclean R, ...